Proprietary Data Assets Supporting Pharmaceutical Commercialization Teams

Data Asset Library

49,000 Commercial plans
across 290 insurers

99.8% Commercial Lives

>60 Drug Classes in 12 therapeutic areas

1,000s of Medical Policies

6,500 Medicare plans
across 250 insurers

100% of Medicare Lives

>95% Insured Lives

>1,000 Formulary Tier and Cost Elements

~100 Copay Assistance Costs

Filling Data “Gaps” to Optimize Decision-Making

	PHARMSPECTIVE	Legacy Data Suppliers
Formulary tier / Preferred or Non-Preferred / PA status (Yes or No) / Step edit (Yes or No)	✓	✓
Medical and pharmacy deductibles / OOP maximums	✓	✕
Patient OOP cost detail by formulary tier, total by month, total by year, up to OOP max	✓	✕
Quality-of-access comparisons based on deductibles, OOP max, patient cost sharing	✓	✕
PA requirements specifically broken down by step edit details and documentation requirements	✓	✕
Copay accumulators / Maximizerd impact on patient spend and lived impacted	✓	✕
Patient cost comparisons within/between payers and drugs to assess rebate attractiveness	✓	✕
Segmentation of high deductibles vs. medium/low deductible plans	✓	✕
Copay Assistance Program analysis for Commerical patients	✓	✕
Cost details for Medicare in coverage gap and catastrophic phases	✓	✓